Novavax, Inc. (NVAX)
7.445
+0.10
(+1.43%)
USD |
NASDAQ |
Jul 30, 16:00
7.445
0.00 (0.00%)
After-Hours: 16:31
Novavax Cash from Operations (Quarterly) : -32.42M for March 31, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -32.42M |
| December 31, 2025 | -39.48M |
| September 30, 2025 | 107.80M |
| June 30, 2025 | -127.46M |
| March 31, 2025 | -185.50M |
| December 31, 2024 | -173.16M |
| September 30, 2024 | -144.81M |
| June 30, 2024 | 314.27M |
| March 31, 2024 | -83.56M |
| December 31, 2023 | -176.78M |
| September 30, 2023 | -39.66M |
| June 30, 2023 | -171.94M |
| March 31, 2023 | -329.18M |
| December 31, 2022 | -117.82M |
| September 30, 2022 | -38.71M |
| June 30, 2022 | -170.90M |
| March 31, 2022 | -88.51M |
| December 31, 2021 | -342.41M |
| September 30, 2021 | -142.14M |
| June 30, 2021 | 144.41M |
| March 31, 2021 | 663.08M |
| December 31, 2020 | -128.57M |
| September 30, 2020 | -6.497M |
| June 30, 2020 | 115.63M |
| March 31, 2020 | -23.11M |
| Date | Value |
|---|---|
| December 31, 2019 | -23.74M |
| September 30, 2019 | -32.26M |
| June 30, 2019 | -30.01M |
| March 31, 2019 | -50.61M |
| December 31, 2018 | -45.27M |
| September 30, 2018 | -33.51M |
| June 30, 2018 | -39.97M |
| March 31, 2018 | -66.08M |
| December 31, 2017 | -35.54M |
| September 30, 2017 | -44.18M |
| June 30, 2017 | -12.40M |
| March 31, 2017 | -44.50M |
| December 31, 2016 | -59.57M |
| September 30, 2016 | -64.97M |
| June 30, 2016 | -63.12M |
| March 31, 2016 | -71.11M |
| December 31, 2015 | -18.25M |
| September 30, 2015 | -28.53M |
| June 30, 2015 | -12.32M |
| March 31, 2015 | -30.79M |
| December 31, 2014 | -19.47M |
| September 30, 2014 | -16.08M |
| June 30, 2014 | -11.07M |
| March 31, 2014 | -21.51M |
| December 31, 2013 | -10.97M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Moderna, Inc. | -630.00M |
| Pfizer Inc. | 2.615B |
| Agenus, Inc. | -35.95M |
| Fate Therapeutics, Inc. | -30.82M |
| Recursion Pharmaceuticals, Inc. | -81.10M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -28.36M |
| Cash from Financing (Quarterly) | 37.68M |
| Free Cash Flow | -97.62M |
| Free Cash Flow Per Share (Quarterly) | -0.2064 |
| Free Cash Flow to Equity (Quarterly) | -50.70M |
| Free Cash Flow to Firm (Quarterly) | -28.22M |
| Free Cash Flow Yield | -7.85% |